Recent studies have shown that GADD45α expression is frequently down-regulated in CML, and down-regulation of GADD45α induces tumour cell proliferation, leukaemogenesis and CML progression [26–29]. The gene discussed is GADD45A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.